Jaguar Health Analyst Price Targets - Benzinga

Jaguar Health Inc

JAGXNASDAQ

Trade with Public

Trade with Public

$5.00

-0.62-11.03%

最終更新: Oct 7, 7:58 PM

$4.98

-0.64-11.39%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

Jaguar Health Analyst Price Targets - Benzinga

Jaguar Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Jaguar Health (JAGX).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$31500Upside to Avg. PT+632430.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 19, 2025	First Berlin	Christian Orquera	Initiate	Buy	$60

Analyst Ratings News

PRO
First Berlin Initiates Coverage On Jaguar Health with Buy Rating, Announces Price Target of $60

First Berlin analyst Christian Orquera initiates coverage on Jaguar Health (NASDAQ:JAGX) with a Buy rating and announces Price Target of $60.

Benzinga Newsdesk

UPDATE: Ladenburg Thalmann Says Jaguar Health Price Target Reflects 1-For-3 Reverse Stock Split And Higher Revenue Anticipated Through Commercialization Within Veterinary Market

Bill Haddad

UPDATE: Ladenburg Thalmann Says Jaguar Health Price Target Reflects 1-For-3 Reverse Stock Split And Higher Revenue Anticipated Through Commercialization Within Veterinary Market

Bill Haddad

Ladenburg Thalmann Raises Jaguar Health Price Target To $13

Bill Haddad

Why Jaguar Health Shares Are Trading Higher Today

Jaguar Health (NASDAQ: JAGX) shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a $5 price target.

Bill Haddad

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021

Benzinga Insights